TransMedics Group (TMDX)
(Delayed Data from NSDQ)
$120.55 USD
+1.58 (1.33%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $120.51 -0.04 (-0.03%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth A Momentum A VGM
Fundamental Charts
About Dividend Yield (TTM)
TransMedics Group, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Instruments industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
TMDX 120.55 +1.58(1.33%)
Will TMDX be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for TMDX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for TMDX
TMDX Stock Gains Post Q2 Earnings & Revenue Beat, Margins Up
TransMedics (TMDX) Reports Q2 Earnings: What Key Metrics Have to Say
TMDX: What are Zacks experts saying now?
Zacks Private Portfolio Services
TransMedics (TMDX) Q2 Earnings and Revenues Surpass Estimates
Countdown to TransMedics (TMDX) Q2 Earnings: Wall Street Forecasts for Key Metrics
Veracyte (VCYT) Soars 7.0%: Is Further Upside Left in the Stock?
Other News for TMDX
Morgan Stanley Raises Price Target for TMDX to $123 | TMDX Stock News
What TransMedics Just Taught Me About Trusting The Algorithm
TransMedics: Continued Strength Suggests Further Upside
TransMedics Group Inc (TMDX) Announces Inducement Grants to New Employees | TMDX stock news
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) | TMDX Stock News